Trial Profile
Stroke Prevention With Abciximab in Carotid Endarterectomy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Abciximab (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions
- 17 Dec 2015 Status changed from discontinued to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
- 27 Nov 2005 New trial record.